Company news
Innocare Pharma Ltd. Class A (SSE:688428) news
Every Innocare Pharma Ltd. Class A press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases — page 3
Announcement on Convening the 2024 Semi-Annual Performance Briefing
August 13, 2024
Announcement on Voluntary Disclosure of Completing the 1st Administration of ICP-332 in Patients in the United States
July 24, 2024
Indicative Announcement on Change in Equity of Shareholder with Over 5% Shares
July 19, 2024
Announcement on the "Corporate Value and Return Enhancement" Action Plan 2024
July 17, 2024